Category Archives: Stock Chit Chat
Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010
Alexza Pharmaceuticals, Inc. (Nasdaq:ALXA – News) announced today that company Senior Vice President and Chief Financial Officer, August J. Moretti will present during the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference. The Alexza presentation will be on Friday, August 13, 2010 at 10:40 am ET. The presentation will be webcast from the Southampton [...]
RPRX Back in Play
Penny stock picks gave the heads up on RPRX in June on Proellex lift, and now there could be a chance to make more money on this penny stock play with Androxal. And we have are adding this to our radar on FDA news for Androxal. RPRX : (Nasdaq) Are awaiting response from the FDA [...]
ARNA Arena Pharma stock offering
Arena Pharmaceuticals Inc. said Friday it expects to receive about $60 million before expenses from a direct public offering of stock to entities tied to the health investment firm Deerfield Management. Arena, which is based in San Diego, said it will sell a total of about 8.9 million shares for $6.70 per share. The offering [...]
Arena JPMorgan downgrade
Shares of Arena Pharmaceuticals Inc. fell Monday after a JPMorgan analyst recommended a cautious stance on the stock, citing the near-term risks compared with the rewards for the obesity drug lorcaserin. THE SPARK: Analyst Cory Kasimov downgraded shares to “Neutral” from “Overweight” citing the stock’s jump following a Food and Drug Administration panel recommendation for [...]
VVUS rejection no supprise
VVUS with a FDA rejection, if you was watching Adams Feuerstein’s live blog you will already know why this drug failed. There was not enough long term data to support the long term side effects of its new drug qnexa. The advisory committee to the Food and Drug Administration voted 10 to 6 that the [...]
VVUS going to open after hours 6.00pm
Just of the wire VVUS is going to trade @ 6.00pm. http://www.nasdaqtrader.com/Trader.aspx?id=Tradehalts
Biodel Announces Research Grants by Juvenile Diabetes Research Foundation
Biodel Announces Research Grants by Juvenile Diabetes Research Foundation to Evaluate Use of VIAject(R) in Treatment of Diabetes July 12, 2010 – Biodel Inc. (Nasdaq: BIOD) announced today the award of two research grants by the Juvenile Diabetes Research Foundation (www.jdrf.org) to Stanford University and Oregon Health & Science University (OHSU) to evaluate the use [...]
VVUS :NASDAQ Added to our watch list
The next few weeks could start to get very interesting we have Vivus VVUS :NASDAQ coming up for the FDA panel meeting on the 15th of July. Qnexa could be the new miracle weight loss drug that we have all been waiting for if the FDA give it the thumbs up, pennystocpicksus.com are looking for [...]
ANX Shareholder Meeting 30th June
The shareholder meeting for Adventrx Pharmaceuticals, Inc ANX : (AMEX) is on the the 30th of June, last trade $1.85 could see a little run into the meeting, keep this on your watch list for the next few days.
ACAD featured Phase 3 play
We have added ACADIA Pharmaceuticals Inc. (ACAD): Nasdaq to our featured and our watch list today and ask you to do some research on this company. We just love the pharma tech plays specially the smaller ones as they could have potential for big moves. ACADIA Pharmaceuticals Inc. (ACAD) : Nasdaq ) Currently trading on [...]